Download FREE Sample
Artificial Intelligence (AI) in Pathology involves using advanced machine learning and deep learning algorithms to analyze digital pathology images for diagnosis, prognosis, and research. Traditionally, pathology relies on examining tissue samples under a microscope to identify abnormalities like cancer. With digital pathology, where glass slides are scanned to produce high-resolution digital images, AI now assists in interpreting these images quickly, consistently, and accurately. AI is mainly used in cancer diagnosis, including breast, prostate, and gastrointestinal cancers, helping to recognize patterns, classify tissue types, grade tumours, and detect biomarkers. It also contributes significantly to clinical research, drug development, and biomarker discovery, especially in the pharmaceutical and biotech industries. Overall, AI in pathology enhances efficiency, accuracy, and patient care quality and making it a critical tool in modern precision medicine and integrated diagnostics.
To learn more about this report, download the PDF brochure
Rising diagnostic errors and workload are driving the adoption of AI in pathology
The integration of digital imaging and AI has transformed the landscape of diagnostics in pathology. One of the key reasons for increasing AI use in pathology is the high rate of errors, which can delay treatment and endanger patients' lives. Studies show that manual analysis of pathology slides contributes to diagnostic variability and potential errors. Factors like time constraints or heavy workload can lead to mistakes and oversights in detecting subtle cellular changes or rare events. This surge in errors, especially in case of complex diseases like cancer, is a growing concern globally. Another major challenge is the lack of standardized data for image analysis in pathology. All these limitations have spurred the adoption of AI tools to provide a reliable solution by offering consistent, reproducible, and higte analysis of histopathological images. These systems can identify subtle patterns that might be missed by humans, serving as a crucial second opinion for pathologists, and even predict patient outcomes or responses to therapy.
AI tools are incorporated into pathology workflows via cloud-based platforms or on-site solutions, often alongside whole-slide imaging (WSI) systems. Multiple AI techniques are incorporated in lab workflows including convolutional neural networks (CNNs) for image recognition, unsupervised learning for pattern detection, and multi-modal AI that integrates pathology with genomics or spatial omics data. Explainable AI (XAI) is increasingly important to enhance transparency for clinical applications. Together, these technological advancements reduce diagnostic errors, enhances accuracy and ultimately improves patient safety. As healthcare aims for precision and accountability, AI-powered pathology tools have become an integral part of modern diagnostic workflows.
To learn more about this report, download the PDF brochure
Integration of multi-omics data is enabling holistic and personalized diagnostics in pathology
The convergence of AI-powered pathology with multi-omics data, including genomics, transcriptomics, proteomics, and spatial omics, is quickly transforming precision diagnostics. Unlike traditional pathology methods, which rely solely on visual tissue patterns, this integrated approach enables AI to analyze disease at both cellular and molecular levels.
By combining histological images with detailed molecular data, AI systems can now provide more accurate diagnosis, forecast disease progression, and provide insights, especially in complex diseases like cancer. This trend is driven by both industry and academia, as leading companies and research institutions collaborate to develop multimodal AI platforms. These systems are designed primarily to identify the disease and to understand the factors behind its behaviour by linking image patterns with genetic and protein data. This approach helps create tools that can detect additional biomarkers and sort patients into more precise categories based on how their disease is likely to progress or respond to treatment. By understanding these aspects, clinicians can choose better treatment plans that match each patient-s needs, thereby offering a more practical and personalized care.
Competitive Landscape Analysis
The global AI in pathology market is marked by the presence of established and emerging market players such as Koninklijke Philips N.V.; Hoffmann-La Roche Ltd; "https://www.aiforia.com/">Aiforia Technologies Plc; Indica Labs, Inc.; OptraSCAN, Inc.; Ibex Medical Analytics Ltd; Hologic, Inc.; Akoya Biosciences, Inc.; Paige AI, Inc.; and Proscia, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Recent developments in the AI in pathology market
Recent advancements in AI-powered pathology continue to enhance accuracy, workflow efficiency, and clinical decision support across diagnostic settings. For instance,
- In September 2024, Ibex Medical Analytics introduced a major upgrade to its AI-powered pathology platform, adding enhanced interoperability features, expanded cancer detection capabilities, and a fully automated -zero-click- HER2 scoring tool
- In November 2023, Dedalus and Ibex Medical Analytics launched an end-to-end AI-powered digital pathology solution across Europe by integrating Ibex-s Galen platform into Dedalus-s digital patholo AI-assisted analysis for prostate, breast, and gastric biopsies, enhancing diagnostic accuracy, workflow efficiency, and reproducibility in cancer pathology
Report Scope
| Report Metric | Details |
| Base Year Considered | 2025 |
| Historical Data | 2024 - 2025 |
| 2026 - 2031 | |
| 26% | |
| Market Drivers |
|
|
|
| Segment Scope | Component, Technology, Application, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Koninklijke Philips N.V.; Hoffmann-La Roche Ltd; Aiforia Technologies Plc; Indica Labs, Inc.; OptraSCAN, Inc.; Ibex Medical Analytics Ltd; Hologic, Inc.; Akoya Biosciences, Inc.; Paige AI, Inc.; and Proscia, Inc. among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global AI in Pathology Market Segmentation
This report by Medi-Tech Insights provides thesize of the global AI in pathology market at theregional- and country-level from 2024 to 2031. The report further segments the market based on component, technology, application, and end-user.
Market Size & Forecast (2024-2031), By Component, USD Million
- Software
- Image Analysis & Pattern Recognition
- Predictive Analytics Tools
- Workflow Automation Software
- Diagnostic Decision Support
- Hardware
- Whole Slide Imaging (WSI) Scanners
- Digital Pathology Systems
- AI-Enabled Microscopes
- Services
- Implementation & Integration
- Consulting & Training
- Managed AI Servicetenance & Support
Market Size & Forecast (2024-2031), By Technology, USD Million
- Machine Learning (ML)
- Convolutional Neural Networks (CNNS)
- Generative Adversarial Networks (GANS)
- Recurrent Neural Networks (RNNS)
- Others
- Natural Language Processing (NLP)
- Computer Vision-based Image Analysis
Market Size & Forecast (2024-2031), By Application, USD Million
- Disease Diagnosis & Classification
- Drug Discovery & Development
- Tissue & Cell Analysis
- Clinical Workflow Optimization
- Research & Academic Use
- Others
Market Size & Forecast (2024-2031), By End-user, USD Million
- Hospitals & Pathology Labs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institution
- Others
Market Size & Forecast (2024-2031), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the AI in pathology market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the AI in pathology market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
